Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa
about
Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaVaccines for Pseudomonas aeruginosa: a long and winding roadCapsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approachProtective immunity against Trichinella spiralis infection induced by a multi-epitope vaccine in a murine model.A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors.Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.Prospects for oral replicating adenovirus-vectored vaccines.New perspectives in the management of Pseudomonas aeruginosa infections.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Regulation of the Coxsackie and adenovirus receptor expression is dependent on cystic fibrosis transmembrane regulator in airway epithelial cells.Adenoviral vector-based strategies against infectious disease and cancer.Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines.Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.Th2-biased immune response and agglutinating antibodies generation by a chimeric protein comprising OmpC epitope (323-336) of Aeromonas hydrophila and LTB.
P2860
Q26772315-8DE67CB1-288F-4F98-8E24-C02B8068E48EQ26852817-222A7FEC-2ECF-43F3-A827-82F3F4C63736Q28607775-8D55B15E-6BF6-474F-B3F4-202EEED9C4EEQ35018796-75839EE3-9371-43F5-9DBE-302F1FFE0816Q36735672-D4D7BEC4-ACB7-4D5E-AAD4-38D662988101Q36966327-5C8A6208-7B2B-43AB-9A28-C6EE7C8D9ED4Q38109356-886C8812-FBE4-4685-B35F-5249C0293E04Q38243221-2EE2ABD5-04A3-4DD3-B44D-5523AEFAB6BCQ38599969-D00492D6-824C-4456-91AC-4C89738BD900Q38751678-D39784B1-E318-40B8-B269-F8AAAC8C7A6DQ38814885-5477C995-A47F-449D-B726-A0B25E85940DQ39390000-30852AA7-9564-42FE-98A2-4614687CFDA2Q40366453-38EEC038-7E3F-4672-8497-29AA0DAD0CD8Q47415600-81409974-5E60-4F27-9C8B-14FC5B6E0505Q47757455-0E374DB6-1B5E-4499-8026-1F80681DC3F0
P2860
Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@ast
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@en
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@nl
type
label
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@ast
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@en
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@nl
prefLabel
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@ast
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@en
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@nl
P2093
P2860
P1433
P1476
Adenovirus-based vaccine with ...... against Pseudomonas aeruginosa
@en
P2093
Anja Krause
Anurag Sharma
Stefan Worgall
P2860
P304
P356
10.1371/JOURNAL.PONE.0056996
P407
P577
2013-02-20T00:00:00Z